Lucknow Speciality Pharma

Tisagenlecleucel Injection
Tisagenlecleucel injection is used to treat B-cell acute lymphoblastic leukemia (ALL) that has come back a second or later time or after other medicines did not work well in patients up to 25 years of age. Leukemia is a type of cancer where the body makes abnormal white blood cells. To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Tisagenlecleucel Injection was approved for medical use in the United States in 2017. It is on the World Health Organization’s List of Essential Medicines.

Tisagenlecleucel Injection Available Price In Lucknow Banaras Nepal

Tisagenlecleucel Injection

  • Generic Brand Available – KYMRIAH
  • API – Tisagenlecleucel
  • Packaging – Infusion Bag
  • Strength – N/A

What is Tisagenlecleucel Injection used for?

Tisagenlecleucel Injection, Kymriah is an immunotherapy medicine used to treat a certain type of acute lymphoblastic leukemia in people who are up to 25 years old. Kymriah is also used to treat certain adult patients with large B-cell lymphoma. Kymriah is given after other treatments have failed.

Facts of Medicines

Tisagenlecleucel Injection

STORAGE AND HANDLING

Tisagenlecleucel Injection must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not use the Ado-trastuzumab Emtansine Injectioninjection beyond the expiration date located on the carton and the vial.).

DOSAGE

Single-dose units contain specific amounts of T-cell depending on the patient’s body weight that are suspended in a patient-specific infusion bag

SIDE EFFECTS

Cytokine release syndrome (79%),Cytokine release syndrome, grades 3-4 (49%), Hypogammaglobulinemia (43%), Infection, unspecified pathogen (41%),Pyrexia (40%)

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions: Monitor for hypersensitivity reactions during with CRS. Monitor for neurological events after treatment with infusion. KYMRIAH. Provide supportive care as needed. Serious Infections: Monitor patients for signs and symptoms of infection;

 KYMRIAH is available only through a restricted program under a treat appropriately.

Risk Evaluation and Mitigation Strategy (REMS) called the Prolonged Cytopenias: Patients may exhibit ≥ Grade 3 cytopenias forKYMRIAH REMS. several weeks following KYMRIAH infusion. Prolonged neutropenia has been associated with increased risk of infection.

FAQs – Medicine Questions

Tisagenlecleucel Injection
What is Kymriah used for?
Kymriah (tisagenlecleucel) is an immunotherapy medicine used to treat a certain type of acute lymphoblastic leukemia in people who are up to 25 years old. Kymriah is also used to treat certain adult patients with large B-cell lymphoma. Kymriah is given after other treatments have failed.
Who makes tisagenlecleucel?
The new approval was based on results from a phase 2 clinical trial , called JULIET, for people with relapsed or refractory DLBCL who previously had at least two systemic cancer treatments or a stem cell transplant. Novartis, the manufacturer of tisagenlecleucel, sponsored the trial.
Is Kymriah a gene therapy?
Kymriah, a cell-based gene therapy, is approved in the United States for the treatment of patients up to 25 years of age with B-cell precursor ALL that is refractory or in second or later relapse. Kymriah is a genetically-modified autologous T-cell immunotherapy.
Where can I buy Tisagenlecleucel Injection?

You can buy Tisagenlecleucel Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Tisagenlecleucel Injection?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Tisagenlecleucel Injection price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

How effective is Kymriah?
Data from the ELARA trial showed Kymriah completely cleared signs of cancer in 66% of previously treated patients, and 86% of patients experienced a response, according to results unveiled at the recent American Society of Clinical Oncology annual meeting.

NEWS / UPDATES